JUN 15, 2017 06:58 PM PDT

One Molecule at the Pinnacle of Gut Health

WRITTEN BY: Kara Marker

Expression of a gene called gp96 has been discovered as vital for the training of T cells, educating these immune fighters to tell the difference between harmful cells like bacteria and viruses and healthy cells, like host cells and food particles. For a healthy gut, this distinction is paramount. 

The story begins with another component of the immune system, cells called professional antigen-presenting cells (pAPCs), which are charged with the important task of training T cells. Antigens are a sort of code that cells express to signal whether they are “good’ or “bad.” pAPCs use a class of proteins called toll-like receptors (TLRs) to camp out on the cell surface and recognize antigens floating by. When an antigen is spotted, pAPCs take advantage of a training opportunity for T cells, showing them how to recognize an antigen.

Here, T cells are conditioned to either target and attack antigens from dangerous pathogens or be tolerant and leave alone harmless agents. The cells responsible for these results are either inflammatory pAPCs or tolerogenic pAPCs, respectively.

From the Medical University of South Carolina, scientists conducted a study to identify the gene gp96 and its role in the training process. The study, published in the journal Scientific Reports, is the first to investigate gp96 as involved in gut homeostasis.

Gp96 is a molecule known to be required for healthy gut function. In the gut, cells must know how to leave alone the healthy bacteria and food particles but attack any dangerous invaders. Therefore, a balance between inflammatory and tolerant T cells, or inflammatory and tolerogenic pAPCs, is very important. In the case of colitis, an inflammatory reaction in the gut, the ratio between inflammatory and tolerant T cells is way out of balance.

Using a genetically altered mouse model that lacked gp96 expression, researchers quickly observed that without the gene’s activity, there is the same imbalanced ratio that leads to colitis. Researchers involved in the experiment believe that a variety of molecular consequences, including pAPCs being less able to travel to the the lymph nodes and less able to recognize antigens, are to blame for this reaction. However, further study is needed to connect the loss of gp96 to the development of human colitis.

"This study shines a light on the pathogenesis of inflammatory bowel disease and offers a positive impact on its future clinical management," explained the senior author of the study, Bei Liu, MD.

Source: Medical University of South Carolina

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 15, 2018
Immunology
JUL 15, 2018
Enzyme Pathway Mediates Immune Response to Chagas Disease
The enzyme, PI3Kγ, regulates the immune response to T. cruzi, the cause of Chagas Disease. Manipulation of this enzyme may lead to better treatment of T. cruzi....
OCT 08, 2018
Immunology
OCT 08, 2018
Natural Killer Cells to Aid in Cancer Therapy
Researchers utilize nanoparticles to stimulate NK cells that induce tumor cells to express PDL1, a protein involved in immune response messaging...
OCT 09, 2018
Immunology
OCT 09, 2018
Complement Function Expands
Additional roles to complement protein C3 have been described in work performed by a team of researchers at the Lund University in Sweden...
OCT 24, 2018
Immunology
OCT 24, 2018
Reduce Your Brain Inflammation!
Researchers revise the understanding of microglial cells in neuroinflammatory diseases to suggest immune checkpoints as a means of potentially reversal of the disorders....
NOV 07, 2018
Immunology
NOV 07, 2018
Herd Protection Against Measles
A 26-year-old leukemia patient dies from exposure to measles. Herd immunity can offer a level of protection for those with impaired immune systems....
NOV 14, 2018
Immunology
NOV 14, 2018
Rapid Tumor Targeting
Researchers at the University of California Irvine have developed a technology that will rapidly identify and target T cell receptors for tumor specific antigens...
Loading Comments...